Targeting of Insulin-Like Growth Factor Type 1 Receptor in Ewing Sarcoma: Unfulfilled Promise or a Promising Beginning?

Ítems similars

• Targeting the Insulin-Like Growth Factor 1 Receptor in Ewing's Sarcoma: Reality and Expectations
  per: Olmos, David, et al.
  Publicat: (2011)
• Anti-insulin growth factor receptor therapy in Ewing sarcoma
  per: Isakoff, Michael S, et al.
  Publicat: (2009)
• β-Arrestin–biased agonism as the central mechanism of action for insulin-like growth factor 1 receptor–targeting antibodies in Ewing’s sarcoma
  per: Zheng, Huiyuan, et al.
  Publicat: (2012)
• Preliminary Efficacy of the Anti-Insulin–Like Growth Factor Type 1 Receptor Antibody Figitumumab in Patients With Refractory Ewing Sarcoma
  per: Juergens, Heribert, et al.
  Publicat: (2011)
• Targeted Morphoproteomic Profiling of Ewing's Sarcoma Treated with Insulin-Like Growth Factor 1 Receptor (IGF1R) Inhibitors: Response/Resistance Signatures
  per: Subbiah, Vivek, et al.
  Publicat: (2011)